ArticleBMJ medicine2026

Accumulation and attenuation of cardiovascular benefit with glucagon-like peptide 1 receptor agonists.

Jonathan A Batty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.